ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings
  • Abstract Number: 307 • 2015 ACR/ARHP Annual Meeting

    Screening for Pulmonary Hypertension in the Anti-Synthetase Syndrome; Utility of Four Different Screening Approaches

    Helena Andersson1, Ivar Sjaastad2, Thomas Schwartz2, Torhild Garen3, T. Mogens Aalokken4 and Øyvind Molberg1, 1Department of Rheumatology, Institute of Clinical Medicine, Oslo University Hospital, Oslo, Norway, 2Institute for Experimental Medical Research, Oslo University Hospital, Oslo, Norway, 3Rheumatology, Department of Rheumatology, Oslo University Hospital, Oslo, Norway, 4Department of Radiology, Oslo University Hospital, Oslo, Norway

    Background/Purpose: Pulmonary hypertension (PH) is a feared complication of the anti-synthetase syndrome (ASS) and has previously been reported to occur in 8% of the patients…
  • Abstract Number: 308 • 2015 ACR/ARHP Annual Meeting

    Nailfold Capillaroscopy in Patients with Early Onset-Dermatomyositis

    Renata Miossi, Fernando Henrique Carlos de Souza and Samuel Katsuyuki Shinjo, Rheumatology Division, Rheumatology Division, Faculdade de Medicina da USP, São Paulo, Brazil

    Background/Purpose: Nailfold capillaroscopy (NC) has been demonstrated to be an important tool in the treatment of patients with juvenile dermatomyositis (JDM) and systemic sclerosis. However,…
  • Abstract Number: 309 • 2015 ACR/ARHP Annual Meeting

    Plasma Levels of Heat Shock Protein 90 Are Increased in Idiopathic Inflammatory Myopathies and Correlate with Disease Activity, Skeletal Muscle, Heart and Lung Involvement

    Hana Storkanova1, Olga Krystufkova2, Martin Klein3, Herman F Mann1, Lucia Vernerova2, Maja Spiritovic4, Josef Zámecník5, Karel Pavelka6, Ladislav Senolt3, Jiri Vencovsky1 and Michal Tomcík1, 1Institute of Rheumatology, Department of Rheumatology, 1st Faculty of Medicine, Charles University, Prague, Czech Republic, 2Institute of Rheumatology and Department of Rheumatology, 1st Faculty of Medicine, Charles University, Prague, Czech Republic, 3Institute of Rheumatology and Department of Rheumatology, 1st Faculty of Medicine, Charles University, Prague, Czech Republic, Prague, Czech Republic, 4Faculty of Physical Education and Sport, Charles University, Prague, Czech Republic, 5Department of Pathology and Molecular Medicine, 2nd Medical School and University Hospital Motol, Charles University, Prague, Czech Republic, 6Charles University, Prague, Czech Republic

    Background/Purpose: Heat shock proteins (Hsps) are chaperones playing important roles in skeletal muscle physiology, adaptation to exercise or stress, and in activation of inflammatory cells.…
  • Abstract Number: 310 • 2015 ACR/ARHP Annual Meeting

    Hyaluronic Acid Injections in Knee Osteoarthritis Patients Are Associated with Delay to Knee Arthroplasty

    Kevin Ong1, Allen Anderson2, Edmund Lau3, Faizan Niazi4, Anke Fierlinger4, Steven Kurtz1 and Roy Altman5, 1Exponent, Inc., Philadelphia, PA, 2Tennessee Orthopaedic Alliance, Powderly, KY, 3Exponent, Inc., Menlo Park, CA, 4Ferring Pharmaceuticals, Inc., Parsippany, NJ, 5David Geffen School of Medicine, UCLA, Los Angeles, CA

    Background/Purpose: Although only few nonoperative treatment options for knee osteoarthritis (OA) are available, there continues to be debate about the effectiveness of hyaluronic acid (HA)…
  • Abstract Number: 311 • 2015 ACR/ARHP Annual Meeting

    Comparison Between Intra Articular Ozone and Placebo in the Treatment of Knee Osteoarthritis: A Multicentric, Comparative, Randomized and Double-Blinded Clinical Trial

    Carlos Jesus1, Virginia Trevisani2,3 and Fânia Santos4, 1Health Evidence Based, Escola Paulista de Medicina - Universidade Federal de São Paulo, São Paulo, Brazil, 2Health Evidence Based, Universidade Federal de São Paulo, Sâo Paulo, Brazil, 3Health Evidence Based, Universidade Federal de São Paulo, São Paulo, Brazil, 4Geriatrics and Gerontology Departament, Escola Paulista de Medicina - Universidade Federal de São Paulo, São Paulo, Brazil

    Background/Purpose:  Osteoarthritis (OA) is a common, progressive condition, which is associated with severe pain, functional disability and impairment of health related quality of life, causing…
  • Abstract Number: 312 • 2015 ACR/ARHP Annual Meeting

    Safety, Efficacy and Biomarker Outcomes of a Novel, Intra-Articular, Injectable, Wnt Inhibitor (SM04690) in the Treatment of Osteoarthritis of the Knee: Interim, Exploratory Analysis of Results from a Randomized, Double-Blind, Placebo-Controlled Phase 1 Study

    Yusuf Yazici1, Timothy E. McAlindon2, Roy Fleischmann3, Allan Gibofsky4, Nancy E. Lane5, Alan J. Kivitz6, Nebojsa Skrepnik7, Eddie Armas8, Christopher J. Swearingen1, Anita DiFrancesco1, Jeyanesh R. S. Tambiah1, John Hood1 and Marc C. Hochberg9, 1Samumed, San Diego, CA, 2Tufts Medical Center, Boston, MA, 3University of Texas Southwestern Medical Center, Dallas, TX, 4Weill Cornell Medical College and Hospital for Special Surgery, New York, NY, 5UC Davis Medical Center, Sacramento, CA, 6Altoona Center for Clinical Research, Duncansville, PA, 7Tucson Orthopaedic Institute, Tucson, AZ, 8Well Pharma Medical Research, Miami, FL, 9University of Maryland School of Medicine, Baltimore, MD, USA, Baltimore, MD

    Background/Purpose: Knee osteoarthritis (OA) is characterized by the destruction of articular cartilage, subchrondral bone alterations and varying degrees of synovitis. Current OA treatments are limited…
  • Abstract Number: 313 • 2015 ACR/ARHP Annual Meeting

    Magnetic Resonance Imaging Outcomes Using an Intra-Articular Injection (SM04690) in the Treatment of Osteoarthritis of the Knee: Interim, Exploratory Analysis of Results from a Randomized, Double-Blind, Placebo-Controlled, Phase 1 Study

    Yusuf Yazici1, Sharmila Majumdar2, Timothy E. McAlindon3, Roy Fleischmann4, Allan Gibofsky5, Marc C. Hochberg6, Christopher J. Swearingen1, Anita DiFrancesco1, Jeyanesh R. S. Tambiah1, John Hood1 and Nancy E. Lane7, 1Samumed, San Diego, CA, 2Radiology, UCSF School of Medicine, San Francisco, CA, 3Rheumatology, Tufts Medical Center, Boston, MA, 4University of Texas Southwestern Medical Center, Dallas, TX, 5Weill Cornell Medical College and Hospital for Special Surgery, New York, NY, 6Department of Medicine, University of Maryland, Baltimore, MD, 7Center for Musculoskeletal Health, Univ of California at Davis, Sacramento, CA

    Background/Purpose: Knee osteoarthritis (OA) is characterized by the destruction of articular cartilage, subchrondral bone alterations and varying degrees of synovitis. Current OA treatments are limited…
  • Abstract Number: 314 • 2015 ACR/ARHP Annual Meeting

    A Double-Blind, Randomized, Controlled, Four Parallel Arm, Dose-Finding Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of Single Intra-Articular (IA) Injections of Fasitibant in Patients with Symptomatic OA of the Knee

    Claudia Gabriele Werner1, Karel Pavelka2, Andrea Nizzardo3, Cristina Rossi3, Simona Scartoni3, Maria Paola Contini3, Serena di Molfetta3, Monica Bertolotti3, Angela Capriati3 and Carlo Alberto Maggi4, 1Clinical Research, A. Menarini Research & Business Service GmbH, Berlin, Germany, 2Institute of Rheumatology and Department of Rheumatology, First Faculty of Medicine, Charles University, Prague, Czech Republic, 3Clinical Research Department, Menarini Ricerche S.p.A., Florence, Italy, 4Menarini Ricerche S.p.A., Florence, Italy

    Background/Purpose: Fasitibant (FAS) is a competitive, potent and selective antagonist of the bradykinin B2 receptor administered IA for SOAK. In response to positive outcomes in…
  • Abstract Number: 315 • 2015 ACR/ARHP Annual Meeting

    Structural Effects of Sprifermin in Knee Osteoarthritis: A Post-Hoc Analysis on Cartilage and Non-Cartilaginous Tissue Alterations

    Frank Roemer1, Aida Aydemir2, Stefan Lohmander3, Michel Crema4, Monica D. Marra5, Norma Muurahainen2, Felix Eckstein6 and Ali Guermazi7, 1Radiology, Boston University School of Medicine, Boston, MA, 2EMD Serono, Billerica, MA, 3Lund University, Lund, Sweden, 4Department of Radiology, Boston University School of Medicine, Boston, MA, 5Department of Radiology, BUSM, Boston, MA, 6Paracelsus Med Univ, Chondrometrics GmbH, Salzburg, Austria, 7Boston University School of Medicine, Boston, MA

    Background/Purpose: A randomized, double-blind, placebo-controlled phase 1b clinical trial of sprifermin (rhFGF18) in knee OA assessed central medial tibio-femoral compartment cartilage thickness on quantitative MRI…
  • Abstract Number: 316 • 2015 ACR/ARHP Annual Meeting

    Effect of Vitamin D on Effusion-Synovitis in Knee Osteoarthritis:  a Randomized Controlled Trial

    Xia Wang1, Flavia Cicutinni2, Xingzhong Jin1, Benny Samuel Eathakkattu Antony3, Anita Wluka2,4,5, Weiyu Han1, Leigh Blizzard6, Tania Winzenberg7, Graeme Jones8 and Changhai Ding8, 1Menzies institute for medical research, University of Tasmania, Hobart, Australia, 2Department of Epidemiology and Preventive Medicine, School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia, 3Musculoskeletal, Menzies Research Institute Tasmania, University of Tasmania, Hobart, Australia, 4Epidemiology & Preventive Med, Monash University, Melbourne, Australia, 5Department of Epidemiology and Preventive Medicine, Monash University, Armadale, Australia, 6Statistics, Menzies Research Institute Tasmania, University of Tasmania, Hobart, Tasmania, Australia, 7Menzies Institute for Medical Research, University of Tasmania, Hobart,7000, Australia, 8Musculoskeletal Unit, Menzies Institute for Medical Research, University of Tasmania, Hobart, Australia

    Background/Purpose: To examine the effect of vitamin D supplementation on synovial inflammation in patients with knee osteoarthritis (OA) and low vitamin D levels over 24…
  • Abstract Number: 317 • 2015 ACR/ARHP Annual Meeting

    Relation of Incident Bisphosphonate Use to Trajectory of Joint-Space Width

    Tuhina Neogi1, Na Lu2, Jingbo Niu1, Jeffrey Duryea3 and Yuqing Zhang1, 1Clinical Epidemiology Research and Training Unit, Boston University School of Medicine, Boston, MA, 2Boston University School of Medicine, Boston, MA, 3Radiology, Brigham and Women's Hospital, Boston, MA

    Background/Purpose: Trials regarding bisphosphonate (Bisph) effects in knee osteoarthritis (OA) have been conflicting, and are unable to provide insights into long-term effects. While Bisph may…
  • Abstract Number: 318 • 2015 ACR/ARHP Annual Meeting

    Dual Variable Domain-Immunoglobulin (Dvd-Ig™) Abt-981 Simultaneously and Dose-Dependently Inhibits Interleukin-1 Αlpha and -1 Βeta in Subjects with Knee Osteoarthritis

    Susanne X. Wang1, Ralf Loebbert2, Erik Sampson3, Mary Saltarelli1, Jeroen Medema1 and Feng Hong3, 1AbbVie Inc., North Chicago, IL, 2AbbVie Deutschland GmbH & Co. KG, Ludwigshafen, Germany, 3AbbVie Inc., Worcester, MA

    Background/Purpose: ABT-981 is a novel human Dual-Variable Domain Immunoglobulin (DVD-Ig™) that inhibits interleukin (IL)-1α and IL-1β. The purpose of this study is to evaluate IL-1α…
  • Abstract Number: 319 • 2015 ACR/ARHP Annual Meeting

    Phase 1 Studies of Anti-Interleukin-1 Dual-Variable Domain Immunoglobulin in Healthy Subjects and Patients with Osteoarthritis

    Susanne X. Wang1, Wei Liu1, Ping Jiang1, Martin Okun1, Richard Preston2, Carlos J. Lozada2, David Carter1 and Jeroen Medema1, 1AbbVie Inc., North Chicago, IL, 2University of Miami Miller School of Medicine, Miami, FL

    Background/Purpose: Interleukin (IL)-1 is a catabolic cytokine that plays an important role in pathogenesis and progression of osteoarthritis (OA). Two phase 1 clinical trials investigated…
  • Abstract Number: 320 • 2015 ACR/ARHP Annual Meeting

    Effectiveness of Bracing in Elderly with Knee Osteoartritis: A Randomized Controlled Trial

    Christine Brumini Sr.1, Jamil Natour2, Lais Yumi Miura1 and Anamaria Martinez2, 1Rheumatology, University Federal of Sao Paulo, São Paulo, Brazil, 2Rheumatology Division, Federal University of Sao Paulo, Sao Paulo, Brazil

    Background/Purpose: Osteoarthritis (OA) is highly prevalent in the elderly, with the knee being the most commonly affected joint in this population. Knee braces are often…
  • Abstract Number: 321 • 2015 ACR/ARHP Annual Meeting

    Effects of Bariatric Surgery on Long-Term Quality of Life Outcomes for Obese Patients with Osteoarthritis

    Ankita Satpute1, Deepak L. Bhatt2, Sangeeta Kashyap3, Philip Schauer4, Colin O'Rourke5, James Bena5 and M. Elaine Husni6, 1Case Western Reserve University School of Medicine, Cleveland, OH, 2Brigham and Women’s Hospital Heart & Vascular Center, Boston, MA, 3Endocrinology, Diabetes and Metabolism, Cleveland Clinic Foundation, Cleveland, OH, 4General Surgery, Cleveland Clinic Foundation, Cleveland, OH, 5Department of Quantitative Health Sciences, Cleveland Clinic Foundation, Cleveland, OH, 6Rheumatology Dept A50, Cleveland Clinic Foundation, Cleveland, OH

    Background/Purpose: Osteoarthritis (OA) remains a debilitating burden for patients and a challenge to their physicians, as there is no known cure. Obesity has been linked…
  • « Previous Page
  • 1
  • …
  • 1708
  • 1709
  • 1710
  • 1711
  • 1712
  • …
  • 2425
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology